Masimo (MASI) Competitors $160.01 +1.07 (+0.68%) As of 09:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MASI vs. AMN, VEEV, DXCM, STE, PODD, HOLX, BAX, GMED, TFX, and ITGRShould you be buying Masimo stock or one of its competitors? The main competitors of Masimo include AMN Healthcare Services (AMN), Veeva Systems (VEEV), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Teleflex (TFX), and Integer (ITGR). These companies are all part of the "medical" sector. Masimo vs. Its Competitors AMN Healthcare Services Veeva Systems DexCom STERIS Insulet Hologic Baxter International Globus Medical Teleflex Integer AMN Healthcare Services (NYSE:AMN) and Masimo (NASDAQ:MASI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Is AMN or MASI more profitable? AMN Healthcare Services has a net margin of -5.80% compared to Masimo's net margin of -25.06%. Masimo's return on equity of 22.56% beat AMN Healthcare Services' return on equity.Company Net Margins Return on Equity Return on Assets AMN Healthcare Services-5.80% 13.39% 4.17% Masimo -25.06%22.56%10.00% Which has more volatility & risk, AMN or MASI? AMN Healthcare Services has a beta of 0.18, suggesting that its stock price is 82% less volatile than the S&P 500. Comparatively, Masimo has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Which has better valuation & earnings, AMN or MASI? AMN Healthcare Services has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAMN Healthcare Services$2.85B0.25-$146.98M-$4.33-4.38Masimo$2.13B4.08-$304.90M-$9.17-17.45 Do analysts rate AMN or MASI? AMN Healthcare Services presently has a consensus price target of $32.08, suggesting a potential upside of 69.13%. Masimo has a consensus price target of $191.60, suggesting a potential upside of 19.74%. Given AMN Healthcare Services' higher possible upside, research analysts clearly believe AMN Healthcare Services is more favorable than Masimo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AMN Healthcare Services 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Do institutionals and insiders hold more shares of AMN or MASI? 99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by insiders. Comparatively, 16.9% of Masimo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer AMN or MASI? In the previous week, AMN Healthcare Services had 2 more articles in the media than Masimo. MarketBeat recorded 8 mentions for AMN Healthcare Services and 6 mentions for Masimo. AMN Healthcare Services' average media sentiment score of 1.27 beat Masimo's score of 1.09 indicating that AMN Healthcare Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Masimo 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAMN Healthcare Services beats Masimo on 9 of the 16 factors compared between the two stocks. Get Masimo News Delivered to You Automatically Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASI vs. The Competition Export to ExcelMetricMasimoMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.61B$6.92B$5.70B$9.55BDividend YieldN/A1.30%4.71%4.04%P/E Ratio-17.3124.6628.1719.95Price / Sales4.0855.55390.0667.71Price / Cash25.3920.5636.3258.75Price / Book8.214.708.305.77Net Income-$304.90M$174.54M$3.25B$259.28M7 Day Performance-3.02%-3.34%-1.99%-2.40%1 Month Performance-4.88%0.51%8.68%9.41%1 Year Performance50.33%7.23%34.95%16.67% Masimo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASIMasimo4.1258 of 5 stars$160.01+0.7%$191.60+19.7%+47.0%$8.61B$2.13B-17.315,600Positive NewsUpcoming EarningsAMNAMN Healthcare Services4.4581 of 5 stars$18.52-6.6%$32.08+73.3%-70.0%$708.83M$2.98B-4.282,968Positive NewsVEEVVeeva Systems3.9739 of 5 stars$281.38-0.3%$274.17-2.6%+49.8%$45.98B$2.86B59.617,291Positive NewsDXCMDexCom4.4344 of 5 stars$84.03+0.2%$99.60+18.5%+32.4%$32.95B$4.03B62.7110,300Insider TradeSTESTERIS4.746 of 5 stars$222.55-1.3%$266.50+19.7%-3.4%$21.89B$5.46B35.9017,787Positive NewsUpcoming EarningsPODDInsulet4.5858 of 5 stars$280.96-1.2%$321.00+14.3%+52.0%$19.77B$2.07B50.533,900Positive NewsHOLXHologic4.8073 of 5 stars$63.69-0.5%$77.33+21.4%-17.1%$14.26B$4.03B26.877,063Positive NewsBAXBaxter International4.6674 of 5 stars$27.40-1.3%$36.38+32.7%-19.8%$14.06B$10.77B-24.9138,000Upcoming EarningsGMEDGlobus Medical4.9529 of 5 stars$51.94-7.8%$91.09+75.4%-24.5%$7.03B$2.52B38.765,300Analyst RevisionHigh Trading VolumeTFXTeleflex4.8887 of 5 stars$109.98-1.0%$159.63+45.1%-48.0%$4.86B$3.05B34.6914,100Positive NewsUpcoming EarningsITGRInteger3.3585 of 5 stars$111.57-0.8%$146.25+31.1%-8.7%$3.89B$1.72B52.8811,000Earnings Report Related Companies and Tools Related Companies AMN Healthcare Services Alternatives Veeva Systems Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Hologic Alternatives Baxter International Alternatives Globus Medical Alternatives Teleflex Alternatives Integer Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MASI) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredDrone Company Secures Major Defense Contract Amid Sweeping Policy ShiftOn July 10th, the White House and DoD announced a sweeping new directive to fast-track U.S. drone dominance. ...The Tomorrow Investor | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Masimo Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Masimo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
